Intellipharmaceutics International Inc. (IPCIF) ETF
Data as of October 24, 2026
Stockbruh grade: Challenging 0/3 metrics rated Sunny
What does Intellipharmaceutics International Inc. invest in?
Intellipharmaceutics International Inc. operates as a pharmaceutical firm primarily engaged in the research, development, and manufacturing of both novel and generic oral solid dosage medications that feature controlled and targeted release mechanisms.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y CAGR) | ⛅ Moderate | ≥8% = Sunny, 1–8% = Cloudy, <1% = Thunderstorm |
| Dividends | ⛅ Moderate | Dividend yield and consistency |
| Fees (Expense Ratio) | ⛅ Moderate | <0.5% = Sunny, 0.5–1.5% = Cloudy, >1.5% = Thunderstorm |
| Price | $0.15 | Assets Under Management | — |
Common Questions
How have IPCIF's returns been over the last 5 years?
IPCIF has delivered moderate 5-year returns (1%–8% CAGR), rated Cloudy on Stockbruh's weather system. Sign up to see the full return history.
Is IPCIF a good ETF for beginners?
Stockbruh provides a beginner-friendly analysis of IPCIF covering returns (5Y CAGR), dividend yield, and expense ratio. IPCIF has moderate fees. Sign up free to see the full weather-rated breakdown.